NanoVibronix Inc (NASDAQ: NAOV) Receives Cataloging Endorsement for UroShield from Australia

NanoVibronix Inc (NASDAQ: NAOV) announced that the Therapeutic Goods Administration (TGA) endorsed its UroShield to be used by patients in Australia.

Signs Contract with DukeHill Healthcare for Supply of UroShield® and PainShield® in Australia

The company also announced that it earmarked an association with DukeHill Healthcare Pty Ltd to distribute the company’s UroShield® and PainShield® apparatus in Australia. 

Brian Murphy, Chief Executive Officer of NanoVibronix Inc., observed, “Endorsement in Australia is yet one more substantial landmark in the direction of complete commercialization of our products, principally given the severe criterions by which our UroShield device was gaged by TGA. We are excited about associating with DukeHill HC, an engineering front-runner with noteworthy sales possessions and strong circulation competences in Australia. DukeHill HC have by this time retained their original order authenticating their sureness in the equipment and market latent, which we are on program to achieve in the impending week, which should lay a stable basis for instant income acknowledgement.”

Murphy added, “Observing ahead, PainShield, our pain administration expedient, is also now under appraisal by the TGA for cataloging and delivery in Australia as part of our approach for global growth.”

Toni Hill, Managing Director of DukeHill Healthcare Pty Ltd, observed, “We forestall a strong acceptance of UroShield given its Informal to Use, Slightly Intrusive, and Clinically Effective Stage. The UroShield has met the Australian TGA’s demanding monitoring necessities and has been added to the authorized catalogue of healthcare expedients in agreement with the Rules. The cataloging comes at a crucial time for long-term tube patients both in the Public and in Health Care Amenities (Infirmary and Elderly Care) who are at jeopardy of CAUTI. “

About UroShield® and PainShield

UroShield® is an ultrasound-based creation intended to avert microbial settlement and biofilm on indwelling urinary tubes and antibiotic effectiveness, eventually reducing the occurrence of catheter-associated urinary band contagions. UroShield is also envisioned to cut agony and distress related to urinary tube usage.

PainShield is an ultrasound device that transports a restricted ultrasound consequence to handle agony and encourage soft flesh soothing in a directed part, while observing the level of ultrasound vigor at a benign and constant level. Its array of submissions comprises severe and lingering discomfort resolution through its many contrivances of accomplishment. 

Leave a Comment

Your email address will not be published.